“Neurological manifestations of COVID-19” - guideline of the German society of neurology

被引：0
作者：
Peter Berlit
Julian Bösel
Georg Gahn
Stefan Isenmann
Sven G. Meuth
Christian H. Nolte
Marc Pawlitzki
Felix Rosenow
Benedikt Schoser
Götz Thomalla
Thomas Hummel
机构：
[1] Secretary General of the German Society of Neurology,Department of Neurology
[2] Klinikum Kassel,Department of Neurology
[3] DGNI,Department of Neurology and Clinical Neurophysiology
[4] Klinikum Karlsruhe,Department of Neurology
[5] DGNI,Department of Neurology with Institute for Translational Neurology
[6] St. Josef Hospital Moers,Epilepsy Center Frankfurt Rhein
[7] University Hospital Düsseldorf,Main, Center of Neurology and Neurosurgery
[8] Department of Neurology with Experimental Neurology and Center for Stroke Research Berlin (CSB) Charité-University Berlin,Friedrich Baur Institute at the Neurological Department
[9] University Hospital Münster,Department of Neurology, Head and Neurocenter
[10] University Hospital Frankfurt,Interdisciplinary Center for Smelling and Tasting, University ENT Hospital Dresden
[11] LM-University Munich,undefined
[12] University Hospital Hamburg-Eppendorf,undefined
[13] German Society for ENT Medicine,undefined
来源：
Neurological Research and Practice | / 2卷
关键词：
SARS-CoV-2; COVID-19; Anosmia; Hyposmia; Encephalopathy; Encephalitis; Epileptic seizures; Seizure recurrence; Meningoencephalitis; Myelitis; Encephalomyelitis; Neuromuscular diseases; Myositis; Myasthenia gravis; Guillain-Barré syndrome; Miller Fisher syndrome; Critical illness weakness; Critical illness neuropathy/myopathy; Intensive care unit acquired weakness; ECMO; Ventilation; Delirium; Status epilepticus; Stroke; Intracerebral hemorrhage; Intracranial hemorrhage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Infection with the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to a previously unknown clinical picture, which is known as COVID-19 (COrona VIrus Disease-2019) and was first described in the Hubei region of China. The SARS-CoV-2 pandemic has implications for all areas of medicine. It directly and indirectly affects the care of neurological diseases. SARS-CoV-2 infection may be associated with an increased incidence of neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia and neuromuscular diseases.
引用
收藏
相关论文
共 254 条
[41]  
Padroni M(2019)Clinical diagnosis and current management strategies for olfactory dysfunction: A review JAMA Otolaryngology. Head & Neck Surgery 1 365-101
[42]  
Mastrangelo V(1984)Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function Physiology & Behavior 32 419-360
[43]  
Asioli GM(2020)Handlungsempfehlungen DGHNO-KHC und BVHNO für die HNO-Elektiv−/nicht notfallmäßige Behandlung zu Corona-Zeiten (29.04.2020) Laryngorhinootologie 99 265-177
[44]  
Pavolucci L(2014)Prognosis of postviral olfactory loss: Follow-up study for longer than one year American Journal of Rhinology & Allergy 28 1061-1513
[45]  
Abu-Rumeileh S(2006)Recovery of olfactory function following closed head injury or infections of the upper respiratory tract Archives of Otolaryngology – Head & Neck Surgery 132 1708-28
[46]  
Piscaglia MG(2020)Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China JAMA 323 1055-181
[47]  
Pfefferkorn T(2020)Clinical characteristics of coronavirus disease 2019 in China The New England Journal of Medicine 382 383-263
[48]  
Dabitz R(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study Lancet 395 96-S361
[49]  
von Wernitz-Keibel T(2020)Guillain-Barré syndrome associated with SARS-CoV-2 infection: Causality or coincidence? Lancet Neurology 19 354-undefined
[50]  
Aufenanger J(2020)Metabolic aspects of muscle wasting during critical illness Current Opinion in Clinical Nutrition and Metabolic Care 23 175-undefined
12345678910